Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1992 1
1994 1
1999 1
2001 3
2002 3
2006 1
2007 1
2010 1
2011 1
2014 1
2015 3
2016 3
2017 3
2018 2
2019 2
2021 2
2022 7
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Results by year

Filters applied: . Clear all
Page 1
Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer.
Partridge AH, Niman SM, Ruggeri M, Peccatori FA, Azim HA Jr, Colleoni M, Saura C, Shimizu C, Sætersdal AB, Kroep JR, Mailliez A, Warner E, Borges VF, Amant F, Gombos A, Kataoka A, Rousset-Jablonski C, Borstnar S, Takei J, Lee JE, Walshe JM, Ruíz-Borrego M, Moore HCF, Saunders C, Bjelic-Radisic V, Susnjar S, Cardoso F, Smith KL, Ferreiro T, Ribi K, Ruddy K, Kammler R, El-Abed S, Viale G, Piccart M, Korde LA, Goldhirsch A, Gelber RD, Pagani O; International Breast Cancer Study Group; POSITIVE Trial Collaborators. Partridge AH, et al. N Engl J Med. 2023 May 4;388(18):1645-1656. doi: 10.1056/NEJMoa2212856. N Engl J Med. 2023. PMID: 37133584 Free PMC article. Clinical Trial.
Efficacy of Metronomic Oral Vinorelbine, Cyclophosphamide, and Capecitabine vs Weekly Intravenous Paclitaxel in Patients With Estrogen Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer: Final Results From the Phase 2 METEORA-II Randomized Clinical Trial.
Munzone E, Regan MM, Cinieri S, Montagna E, Orlando L, Shi R, Campadelli E, Gianni L, Palleschi M, Petrelli F, Bengala C, Generali D, Collovà E, Puglisi F, Cretella E, Zamagni C, Chini C, Ruepp B, Loi S, Colleoni M; International Breast Cancer Study Group (IBCSG). Munzone E, et al. JAMA Oncol. 2023 Sep 1;9(9):1267-1272. doi: 10.1001/jamaoncol.2023.2150. JAMA Oncol. 2023. PMID: 37440239 Clinical Trial.
Characterization of a novel cfr(D)/poxtA-carrying plasmid in an oxazolidinone-resistant Enterococcus casseliflavus isolate from swine manure, Italy.
Cinthi M, Coccitto SN, D'Achille G, Morroni G, Simoni S, Fioriti S, Magistrali CF, Brenciani A, Giovanetti E. Cinthi M, et al. Among authors: d achille g. J Glob Antimicrob Resist. 2022 Sep;30:308-310. doi: 10.1016/j.jgar.2022.07.007. Epub 2022 Jul 10. J Glob Antimicrob Resist. 2022. PMID: 35830951 Free article. No abstract available.
Clinical and microbiological features of ceftolozane/tazobactam-resistant Pseudomonas aeruginosa isolates in a university hospital in central Italy.
Morroni G, Brescini L, Antonelli A, Di Pilato V, Castelletti S, Brenciani A, D'Achille G, Mingoia M, Giovanetti E, Fioriti S, Masucci A, Giani T, Giacometti A, Rossolini GM, Cirioni O. Morroni G, et al. Among authors: d achille g. J Glob Antimicrob Resist. 2022 Sep;30:377-383. doi: 10.1016/j.jgar.2022.07.010. Epub 2022 Jul 13. J Glob Antimicrob Resist. 2022. PMID: 35842115 Free article.
Co-location of the oxazolidinone resistance poxtA2 and cfr(D) genes on a multiresistance plasmid from a porcine Streptococcus dysgalactiae subsp. equisimilis, Italy.
Coccitto SN, Massacci FR, Cinthi M, Albini E, Cucco L, D'Achille G, Morroni G, Mingoia M, Orsini M, Giovanetti E, Brenciani A, Magistrali CF. Coccitto SN, et al. Among authors: d achille g. J Antimicrob Chemother. 2023 Aug 2;78(8):2099-2102. doi: 10.1093/jac/dkad169. J Antimicrob Chemother. 2023. PMID: 37253052 No abstract available.
Correction: Morroni et al. Antimicrobial Activity of Aztreonam in Combination with Old and New β-Lactamase Inhibitors against MBL and ESBL Co-Producing Gram-Negative Clinical Isolates: Possible Options for the Treatment of Complicated Infections. Antibiotics 2021, 10, 1341.
Morroni G, Bressan R, Fioriti S, D'Achille G, Mingoia M, Cirioni O, Di Bella S, Piazza A, Comandatore F, Mauri C, Migliavacca R, Luzzaro F, Principe L, Lagatolla C. Morroni G, et al. Among authors: d achille g. Antibiotics (Basel). 2022 Mar 30;11(4):464. doi: 10.3390/antibiotics11040464. Antibiotics (Basel). 2022. PMID: 35453287 Free PMC article.
40 results